Research Frontiers just reported results for the first quarter of 2024. More
Articles
XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024
XENE stock results show that Xenon Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. More
PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024
PODD stock results show that Insulet beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024
MGNX stock results show that Macrogenics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
IOVA stock results show that Iovance Biotherapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
PGNY Stock Earnings: Progyny Beats EPS, Misses Revenue for Q1 2024
PGNY stock results show that Progyny beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
VINP Stock Earnings: Vinci Partners Inv Misses EPS, Beats Revenue for Q1 2024
VINP stock results show that Vinci Partners Inv missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
